Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis.

Latent tuberculosis infection Psoriasis Secukinumab

Journal

Case reports in dermatology
ISSN: 1662-6567
Titre abrégé: Case Rep Dermatol
Pays: Switzerland
ID NLM: 101517685

Informations de publication

Date de publication:
Historique:
received: 05 07 2019
accepted: 05 07 2019
entrez: 31 10 2019
pubmed: 31 10 2019
medline: 31 10 2019
Statut: epublish

Résumé

Upon the association of biologic treatments with reactivation of latent tuberculosis infection (LTBI), screening for

Identifiants

pubmed: 31662735
doi: 10.1159/000501989
pii: cde-0011-0023
pmc: PMC6816124
doi:

Types de publication

Case Reports

Langues

eng

Pagination

23-28

Informations de copyright

Copyright © 2019 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Microbiol Spectr. 2016 Oct;4(5):
pubmed: 27763255
PLoS Pathog. 2014 May 15;10(5):e1004099
pubmed: 24831696
Cell Mol Immunol. 2008 Jun;5(3):203-8
pubmed: 18582402
Eur J Immunol. 2012 Sep;42(9):2246-54
pubmed: 22949323
Emerg Microbes Infect. 2016 Feb 03;5:e10
pubmed: 26839146
Immunology. 2013 Oct;140(2):220-31
pubmed: 23721367
Nat Immunol. 2017 May 18;18(6):604-611
pubmed: 28518154
J Immunol. 2010 Apr 15;184(8):4414-22
pubmed: 20212094
Clin Exp Immunol. 2010 Jul 1;161(1):1-9
pubmed: 20491796
J Eur Acad Dermatol Venereol. 2017 May;31(5):774-790
pubmed: 28244153
Expert Opin Drug Saf. 2016 Dec;15(sup1):11-34
pubmed: 27924643
Clin Transl Immunology. 2017 Aug 25;6(8):e152
pubmed: 28868144
J Am Acad Dermatol. 2016 Jul;75(1):83-98.e4
pubmed: 27180926
Nat Immunol. 2017 May 18;18(6):612-621
pubmed: 28518156
Cytokine. 2017 Sep;97:49-65
pubmed: 28570933
Trends Immunol. 2012 Jan;33(1):14-25
pubmed: 22094048
Int J Dermatol. 2015;54(5):594-9
pubmed: 25753908
J Eur Acad Dermatol Venereol. 2017 Dec;31(12):1951-1963
pubmed: 28895202
J Am Acad Dermatol. 2019 Jan;80(1):43-53
pubmed: 30017706
F1000Res. 2017 May 23;6:741
pubmed: 28713557
Rheumatol Int. 2012 Jan;32(1):33-7
pubmed: 20658233
J Allergy Clin Immunol. 2010 Nov;126(5):910-7
pubmed: 20943260
J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1336-41
pubmed: 27256154
Ann Rheum Dis. 2013 Jan;72(1):37-42
pubmed: 22523429
Mediators Inflamm. 2017;2017:8909834
pubmed: 28659665
Cytokine Growth Factor Rev. 2010 Dec;21(6):455-62
pubmed: 21075039
Semin Immunol. 2014 Dec;26(6):497-511
pubmed: 25453227
Front Immunol. 2017 Apr 05;8:294
pubmed: 28424682

Auteurs

Simone Ribero (S)

Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy.

Matteo Licciardello (M)

Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy.

Pietro Quaglino (P)

Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy.

Paolo Dapavo (P)

Medical Sciences Department, Section of Dermatology, University of Turin, Turin, Italy.

Classifications MeSH